Şunu aradınız:: meningokokom (Slovence - İngilizce)

cepivo bexsero je cepivo proti meningokokom skupine b.
bexsero is a meningococcal group b vaccine.

konjugirano cepivo proti meningokokom skupin a, c, w135 in y
meningococcal group a, c, w135 and y conjugate vaccine

menveo konjugirano cepivo proti meningokokom skupin a, c, w135 in y
menveo meningococcal group a, c, w135 and y conjugate vaccine

pred pričetkom jemanja zdravila soliris so bili bolniki cepljeni proti meningokokom.
patients received meningococcal vaccination prior to receipt of soliris.

cepivo proti hemofilusu influence tipa b in proti meningokokom vrste c, konjugirano
haemophilus type b and meningococcal group c conjugate vaccine

bexsero cepivo proti meningokokom skupine b (rekombinantno, komponentno, adsorbirano)
bexsero meningococcal group b vaccine (rdna, component, adsorbed)

antikapsularna protitelesa proti meningokokom ščitijo pred meningokoknimi boleznimi z baktericidnim delovanjem preko komplementa.
anti-capsular meningococcal antibodies protect against meningococcal diseases via complement mediated bactericidal activity.

poleg tega morajo biti vsi bolniki cepljeni proti meningokokom najmanj 2 tedna pred prejemanjem zdravila soliris.
additionally, all patients must be vaccinated against meningococcus at least 2 weeks prior to receiving soliris.

farmakoterapevtska skupina: cepiva, cepiva proti meningokokom, oznaka atc: j07ah08 mehanizem delovanja
pharmacotherapeutic group: vaccines, meningococcal vaccines, atc code: j07ah08 mechanism of action

bexsero suspenzija za injiciranje v napolnjeni injekcijski brizgi cepivo proti meningokokom skupine b (rekombinantno, komponentno, adsorbirano)
bexsero suspension for injection in pre-filled syringe meningococcal group b vaccine (rdna, component, adsorbed)

posamezniki s pomanjkljivostmi komplementa in posamezniki s funkcijsko ali anatomsko asplenijo morda ne bodo dosegli imunskega odziva na konjugirana cepiva proti meningokokom skupin a, c, w135 in y.
individuals with complement deficiencies and individuals with functional or anatomical asplenia may not mount an immune response to meningococcal group a, c, w135 and y conjugate vaccines.

imunogenost so določali z uporabo rsba ali hsba, ki sta biološka označevalca za zaščitno učinkovitost proti meningokokom skupin a, c, w-135 in y.
immunogenicity was measured by using rsba or hsba which are biomarkers for protective efficacy against meningococcal groups a, c, w-135 and y.

o učinkovitosti cepiva so sklepali na podlagi dokaza imunološke neinferiornosti (temelječ na primerjavi razmerij titrov rsba vsaj 8) v primerjavi z odobrenimi cepivi proti meningokokom.
vaccine efficacy was inferred from the demonstration of immunologic non inferiority (based mainly on comparing proportions with rsba titres at least 8) to licensed meningococcal vaccines.

cepivo hexacima se lahko daje istočasno kot druga cepiva, kot so polisaharidna konjugirana cepiva proti pnevmokokom, cepiva proti ošpicam, mumpsu in rdečkam, cepiva proti rotavirusom ali cepiva proti meningokokom.
hexacima can be given at the same time as other vaccines such as pneumococcal vaccines, measles- mumps-rubella vaccines, rotavirus vaccines or meningococcal vaccines.

cepivo rotarix se lahko daje sočasno s katerim koli od naslednjih monovalentnih ali kombiniranih cepiv [vključno s šestvalentnimi cepivi (dtpa- hbv- ipv/ hib)]: cepivom proti davici, tetanusu in oslovskemu kašlju – celotna celica (dtpw), cepivom proti davici, tetanusu in oslovskemu kašlju – acelularno (dtpa), cepivom proti hemofilusu influence tipa b (hib), inaktiviranim cepivom proti otroški ohromelosti (ipv), cepivom proti hepatitisu b (hbv), konjugiranim cepivom proti pnevmokokom in konjugiranim cepivom proti meningokokom serološke skupine c.
rotarix can be given concomitantly with any of the following monovalent or combination vaccines [including hexavalent vaccines (dtpa-hbv-ipv/ hib)]: diphtheria-tetanus-whole cell pertussis vaccine (dtpw), diphtheria-tetanus-acellular pertussis vaccine (dtpa), haemophilus influenzae type b vaccine (hib), inactivated polio vaccine (ipv), hepatitis b vaccine (hbv), pneumococcal conjugate vaccine and meningococcal serogroup c conjugate vaccine.